Segui
Alejandro Campos, M.D.
Alejandro Campos, M.D.
Internal Medicine Resident, BMC; Clinical Research Fellow, Framingham Heart Study, Boston University
Email verificata su bu.edu
Titolo
Citata da
Citata da
Anno
Weight loss outcomes associated with semaglutide treatment for patients with overweight or obesity
W Ghusn, A De la Rosa, D Sacoto, L Cifuentes, A Campos, F Feris, ...
JAMA Network Open 5 (9), e2231982-e2231982, 2022
1372022
Integrative hedonic and homeostatic food intake regulation by the central nervous system: insights from neuroimaging
A Campos, JD Port, A Acosta
Brain sciences 12 (4), 431, 2022
662022
Effectiveness of anti-obesity medications approved for long-term use in a multidisciplinary weight management program: a multi-center clinical experience
G Calderon, D Gonzalez-Izundegui, KL Shan, OA Garcia-Valencia, ...
International Journal of Obesity 46 (3), 555-563, 2022
432022
Effects of heterozygous variants in the leptin-melanocortin pathway on Roux-en-Y gastric bypass outcomes: a 15-Year case–control study
A Campos, L Cifuentes, A Hashem, B Busebee, MD Hurtado-Andrade, ...
Obesity surgery 32 (8), 2632-2640, 2022
342022
Phenotype tailored lifestyle intervention on weight loss and cardiometabolic risk factors in adults with obesity: a single-centre, non-randomised, proof-of-concept study
L Cifuentes, W Ghusn, F Feris, A Campos, D Sacoto, A De la Rosa, ...
EClinicalMedicine 58, 2023
292023
Association of gastric emptying with postprandial appetite and satiety sensations in obesity
D Gonzalez‐Izundegui, A Campos, G Calderon, ML Ricardo‐Silgado, ...
Obesity, 2021
262021
Association between anxiety and eating behaviors in patients with obesity
L Cifuentes, A Campos, MLR Silgado, S Kelpin, J Stutzman, MD Hurtado, ...
Obesity Pillars 3, 100021, 2022
232022
Weight loss and cardiovascular disease risk outcomes of semaglutide: a one-year multicentered study
W Ghusn, S Fansa, D Anazco, E Tama, B Nicolalde, K Gala, A De la Rosa, ...
International Journal of Obesity, 1-6, 2024
122024
Weight loss outcomes associated with semaglutide treatment for patients with overweight or obesity. JAMA Netw Open. 2022; 5 (9): e2231982
W Ghusn, A De la Rosa, D Sacoto, L Cifuentes, A Campos, F Feris
10
A comparison between weight loss outcomes with anti-obesity medications before and during Covid-19 pandemic at a tertiary weight management center
A De la Rosa, W Ghusn, D Sacoto, A Campos, L Cifuentes, F Feris, ...
Obesity Pillars 4, 100046, 2022
92022
Sex as an independent variable in the measurement of satiation: a retrospective cohort study
MD Hurtado, L Cifuentes, A Campos, A De La Rosa, E Kapoor, ...
International Journal of Obesity 46 (12), 2156-2162, 2022
62022
Cardiovascular risk and diseases in patients with and without leptin-melanocortin pathway variants
L Cifuentes, A Campos, D Sacoto, W Ghusn, A De la Rosa, F Feris, ...
Mayo Clinic Proceedings 98 (4), 533-540, 2023
52023
Association between food intake and gastrointestinal symptoms in patients with obesity
W Ghusn, L Cifuentes, A Campos, D Sacoto, A De La Rosa, F Feris, ...
Gastro hep advances 2 (1), 121-128, 2023
52023
The association between previous use of anti‐obesity medication and semaglutide weight loss outcomes
W Ghusn, S Fansa, D Anazco, E Tama, L Cifuentes, K Gala, ...
Diabetes, Obesity and Metabolism 26 (6), 2167-2175, 2024
42024
Effect of caloric intake and macronutrient composition on intestinal cholesterol absorption and bile acids in patients with obesity
AM Hashem, L Cifuentes, G Calderon, ML Ricardo-Silgado, ...
American Journal of Physiology-Gastrointestinal and Liver Physiology 323 (3 …, 2022
42022
Weight Loss Outcomes Associated with Semaglutide Treatment for Patients with Overweight or Obesity. JAMA Network Open, 5, e2231982
W Ghusn, A De la Rosa, D Sacoto, L Cifuentes, A Campos, F Feris, ...
42022
Cumulative effect of obesity phenotypes on body weight and body mass index
W Ghusn, L Cifuentes, D Anazco, S Fansa, E Tama, A Campos, K Gala, ...
International Journal of Obesity, 1-7, 2024
32024
Type 2 Diabetes Remission in Patients with Heterozygous Variants in the Leptin-Melanocortin Pathway after Roux-en-Y Gastric Bypass: A Matched Case–Control Study
D Anazco, W Ghusn, A Campos, L Cifuentes, S Fansa, E Tama, JT Bublitz, ...
Obesity Surgery 33 (11), 3502-3509, 2023
32023
The effect of heterozygous gene variants of the leptin-melanocortin pathway on weight loss following sleeve gastrectomy
F Feris, W Ghusn, A Campos, L Cifuentes, A De la Rosa, D Sacoto, ...
Obesity Surgery 33 (7), 2246-2249, 2023
32023
Neurohormonal response patterns to hunger, satiation, and postprandial fullness in normal weight, anorexia nervosa, and obesity
A Campos, T Marek, G Calderon, W Ghusn, L Cifuentes, LA Sim, ...
Neurogastroenterology & Motility 36 (1), e14695, 2024
12024
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20